Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Antimalarial Treatment on Gametocyte Carriage in Asymptomatic P. Falciparum
NCT00289250Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Plasmodium falciparum malaria comparing Sulfadoxine-pyrimethamine, Sulfadoxine-pyrimethamine plus artesunate and Placebo (3 arms). Primary endpoints: Presence of gametocytes 7 days after treatment and Duration and density of gametocytaemia over 2 months measured by the area under the curve of gametocyte density against time. Started May 2001; status: completed.
02
Drugs
sulfadoxine + pyrimethamineartesunate
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00289250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289250.